Epigenetic drug-sensitive biomarkers for cancer

Researchers perform an epigenome-wide multi-omic high-throughput screen to identify actionable epigenetic drug-sensitive biomarkers.

EY report finds cracks in pharma supply chain operations – Pharmaceutical Technology

Several companies like Kinnate Biopharma, NexImmune and Sage Therapeutics have dramatically cut their workforces under new business strategies. Credit: JHVEPhoto via Shutterstock Following a year

October 4, 2023

FTC votes to ban noncompetes, with far-reaching effects on doctors

The Federal Trade Commission voted to ban noncompete agreements on Tuesday, obviating the restrictive agreements that lock in physicians — and the patients they treat

April 24, 2024

Bluebird in fundraising mode: A $150M public offering and a deal to get cash early from gene therapy sales

Facing a financial void it had hoped to be filled by a priority review voucher, bluebird bio is tapping two different sources to bring in

December 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.